Search results for "OBESITY"

showing 10 items of 1833 documents

Effect of a prenatal lifestyle intervention on physical activity level in late pregnancy and the first year postpartum

2017

Background: Despite documented health benefits for mother and baby, physical activity (PA)-level tends to decline in pregnancy. Overweight/obese and physically inactive women are two selected groups at increased risk of pregnancy complications. Thus, efficient strategies to maintain or increase PA-level in pregnancy and the postpartum period, especially among these women, are warranted. This secondary analysis examined the effect of a prenatal lifestyle-intervention on PA-level in late pregnancy and the first year postpartum, with subanalysis on initially physically active versus inactive and normal-weight versus overweight/obese women. Method: The Norwegian Fit for Delivery (NFFD) randomiz…

European PeoplePhysiologyMaternal Healthlcsh:MedicineWalkingOverweightBody Mass Indexlaw.inventionEndocrinology0302 clinical medicineRandomized controlled trialPregnancylawMedicine and Health SciencesEthnicitiesPublic and Occupational Health030212 general & internal medicinelcsh:Science030219 obstetrics & reproductive medicineMultidisciplinaryObstetricsPostpartum PeriodObstetrics and GynecologyPrenatal CareSports ScienceGestational diabetesPhysiological ParametersGestationFemalemedicine.symptomResearch ArticleAdultmedicine.medical_specialtyNorwegian PeopleEndocrine DisordersPrenatal care03 medical and health sciencesMetabolic EquivalentDiabetes MellitusmedicineHumansObesitySports and Exercise MedicineGestational DiabetesExerciseLife StylePregnancyBiological Locomotionbusiness.industrylcsh:RBody WeightBiology and Life SciencesPhysical Activitymedicine.diseasePhysical FitnessMetabolic DisordersPeople and PlacesWomen's Healthlcsh:QPopulation GroupingsbusinessBody mass indexPostpartum periodPLOS ONE
researchProduct

Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus.

2021

This article also appears in: Health, Medical, and Life Sciences Virtual Issue for Advanced Science.

FGF21General Chemical EngineeringGeneral Physics and AstronomyMedicine (miscellaneous)CODON USAGE BIAS02 engineering and technology01 natural sciencesGLUCOSEACTIVATIONPF-05231023ComputingMilieux_COMPUTERSANDEDUCATIONGeneral Materials SciencegeneticsCells CulturedINSULIN-RESISTANCEFull PaperFatty liverQGeneral Engineeringfibroblast growth factor 21 genetics metabolic metabolic associated fatty liver disease Cells Cultured Enzyme-Linked Immunosorbent Assay Fatty Liver Fibroblast Growth Factors Humans Inflammation LiverFull Papers021001 nanoscience & nanotechnologyPhenotype3. Good healthLiverOBESITY221 Nano-technology0210 nano-technologyReprogrammingEXPRESSIONmedicine.medical_specialtySettore MED/12 - GASTROENTEROLOGIAScienceEnzyme-Linked Immunosorbent Assayfibroblast growth factor 21Biology010402 general chemistryBiochemistry Genetics and Molecular Biology (miscellaneous)metabolic associated fatty liver diseaseInsulin resistancemetabolicInternal medicinemedicineHumansSecretionFGF21 RESISTANCEAlleleInflammationmedicine.disease0104 chemical sciencesFatty LiverFibroblast Growth FactorsEndocrinologyRNA SECONDARY STRUCTURETRANSLATIONHormoneAdvanced science (Weinheim, Baden-Wurttemberg, Germany)
researchProduct

Effect of simvastatin on desaturase activities in liver from lean and obese zucker rats

1993

The effect of simvastatin, a hypocholesterolemic drug, on the biosynthesis of arachidonic acid was studied in obese and lean Zucker rats. After administration of 2 mg/kg body weight/d for 13 d, delta 6 and delta 5 desaturase activities were measured in liver microsomes at two substrate concentrations. In untreated rats, the delta 6 desaturation rate was similar in the obese and lean rats when measured at saturating substrate levels, whereas delta 5 desaturation was lower in the obese animals. Treatment with simvastatin did not change delta 6 desaturation in either phenotype but increased delta 5 desaturation in obese rats to reach the unchanged rate observed in lean animals. The changes wer…

Fatty Acid DesaturasesMaleSimvastatinmedicine.medical_specialtyClinical chemistryIn Vitro TechniquesBiologyLinoleoyl-CoA DesaturaseBiochemistrychemistry.chemical_compoundDelta-5 Fatty Acid DesaturaseInternal medicinemedicineAnimalsLovastatinObesityPhospholipidschemistry.chemical_classificationAnticholesteremic AgentsFatty AcidsOrganic ChemistryMetabolic disordernutritional and metabolic diseasesFatty acidCell Biologymedicine.diseaseHydroxymethylglutaryl-CoA reductaseRatsRats ZuckerEndocrinologychemistrySimvastatinFatty Acids UnsaturatedMicrosomes LiverMicrosomeArachidonic acidLipidologymedicine.drugLipids
researchProduct

The metabolic cascade leading to eicosanoid precursors--desaturases, elongases, and phospholipases A2--is altered in Zucker fatty rats.

2010

Abstract Metabolic syndrome characterized by insulin resistance and obesity is accompanied by severe lipid metabolism perturbations and chronic low-grade inflammation. However, many unresolved questions remained regarding the regulation that underlie dyslipidemia, particularly the regulation of the metabolic cascade (synthesis and release) leading to eicosanoid precursors release. This study was undertaken to investigate the regulation of desaturases/elongases and phospholipases A2 during the establishment of metabolic syndrome. Our results showed that delta-6 desaturase as well as elongase-6 expressions were upregulated in 3-month-old Zucker fatty rats as compared to lean littermates, inde…

Fatty Acid DesaturasesMalemedicine.medical_specialtyFatty Acid ElongasesBlotting WesternPhospholipaseLinoleoyl-CoA DesaturaseGroup VI Phospholipases A2Insulin resistancePhospholipase A2Downregulation and upregulationAcetyltransferasesInternal medicinemedicineAnimalsObesityMolecular BiologyMetabolic SyndromePhospholipase AbiologyReverse Transcriptase Polymerase Chain ReactionGroup IV Phospholipases A2Lipid metabolismCell Biologymedicine.diseaseRatsRats ZuckerFatty LiverPhospholipases A2EndocrinologyEicosanoidLiverbiology.proteinFatty Acids UnsaturatedEicosanoidsMetabolic syndromeInsulin ResistanceBiochimica et biophysica acta
researchProduct

Role of CD36 in Oral and Postoral Sensing of Lipids

2011

Obesity and associated plethora of diseases constitute a major public health challenge worldwide. The conjunction of profound changes in our lifestyle and a thrifty genetic that evolved in an environment of food scarcity largely explains this epidemic situation. Food abundance promotes our specific appetite for the more palatable food generally rich in lipids. It is noteworthy that this attraction for fatty food is not specific to humans. Rats and mice also spontaneously prefer lipid-rich food in a free-choice situation. Detection of lipids in food requires the presence of specific sensors located in strategic places (e.g., oral cavity, small intestine, brain) whose activation results in a …

Fatty foodsCD36digestive oral and skin physiologyZoologyBiologymedicine.diseaseOral cavityObesitySpecific appetitemedicinebiology.proteinEating behaviorFood scienceSensing systemFood scarcity
researchProduct

Strategies to achieve a healthy and balanced diet: fruits and vegetables as a natural source of bioactive compounds

2020

Abstract The main world health problems are obesity and chronic diseases such as diabetes, cancer, and cardiovascular problems. They are etiologically linked with the reduced consumption of fruits and vegetables and increased intake of salt, fats from animal origins, trans fatty acids, sugars, and sugary beverages. Various strategies for educating the public tend to promote the increased consumption of bioactives from fruits and vegetables and dieting, while creating affordable and nutritious foods from sustainable raw materials. These strategies include educating the public about dietary tools and the industrial use of advanced nonthermal food processing and production technologies from re…

Food industrybusiness.industryfood and beveragesRaw materialmedicine.diseaseObesityBiotechnologyFood wasteFood chainHuman nutritionmedicineFood processingmedicine.symptombusinessDieting
researchProduct

Weight Gain Associated with Cinnarizine

1992

OBJECTIVE: To report four cases of cinnarizine-induced weight gain. DATA SOURCES: Case reports from a local obesity center and review articles. DATA EXTRACTION: Data were abstracted from spontaneous comments made by patients to one of the authors, who was a doctor at the clinic, and reviewed by the remaining authors. DATA SYNTHESIS: We reviewed the cases of four women, aged 50–57 years without endocrine or metabolic pathologies, that showed weight gain associated with the intake of cinnarizine for one to two years. No other drugs usually were administered during the period in which the women gained weight, although in two cases cinnarizine was associated with dihydroergocristine in the same…

Food intakePediatricsmedicine.medical_specialtyCinnarizinemedia_common.quotation_subjectAppetiteWeight GainDihydroergocristineCinnarizine03 medical and health sciences0302 clinical medicinemedicineHumansEndocrine systemPharmacology (medical)030212 general & internal medicinemedia_commonbusiness.industryAppetiteMiddle Agedmedicine.diseaseObesityGained weightAnesthesiaVertigoFemalemedicine.symptombusinessWeight gain030217 neurology & neurosurgerymedicine.drugAnnals of Pharmacotherapy
researchProduct

Peripheral Glucagon Like Peptide 2 Analogue Administration Reduces Food Intake in Lean and Diet-Induced Obese Mice

2011

Food intakemedicine.medical_specialtyHepatologybusiness.industryGastroenterologyGlucagon-like peptide-2PeripheralDiet induced obesityEndocrinologyInternal medicinemedicinebusinessGLP-2Diet-induced obeseGastroenterology
researchProduct

Action of an extract from the seeds of Fraxinus excelsior L. on metabolic disorders in hypertensive and obese animal models.

2014

Nuzhenide and GI3, the principal secoiridoids of an extract obtained from the seeds of Fraxinus excelsior L. (FXE), are believed to be the active compounds responsible for the previously reported hypoglycemic effects of this extract. In this study, the effects of FXE were studied in two animal models which are representative of metabolic disorders: spontaneously hypertensive rats (SHR) and obese Zucker rats. SHR were acutely treated (oral gavage) with different doses of FXE. In addition, SHR and Zucker rats were chronically fed (20 or 5 weeks, respectively) with standard chow supplemented with FXE. Acute treatment with FXE (200 mg per kg body weight) decreased systolic blood pressure as in …

Fraxinus excelsior L.Blood GlucoseMalemedicine.medical_specialtyBlood PressureOral gavageInsulin resistanceInternal medicineRats Inbred SHRmedicineAnimalsHumansHypoglycemic AgentsInsulinObesitybusiness.industryPlant ExtractsHypertriglyceridemiaCaptoprilGeneral Medicinemedicine.diseaseObesityRatsRats ZuckerDisease Models AnimalEndocrinologyFraxinusHypertensionSeedsHypoglycemic EffectsMetabolic syndromebusinessFood Sciencemedicine.drugFoodfunction
researchProduct

Role of Endogenous GLP-2 in the Intestinal Adaptation to a Chronic High Fat Diet

2013

GLP-2 receptor expressionintestinal morphometrySettore BIO/09 - Fisiologiaobesity.
researchProduct